Newsroom

Latest news

  • Business
    03 November 2017

    The race goes on

    Over 40 managers from Alvotech and Alvogen made their way to the CPhI in Frankurt last week. The CPhI is one of the most important events for the industry in...

    Read more
  • People
    04 August 2017

    Rasmus Rojkjaer appointed CEO of Alvotech

    Alvotech has appointed Rasmus Rojkjaer as Chief Executive Officer, succeeding Eef Schimmelpennink, who has stepped down from his role. As CEO of Alvotech, Rasmus brings over 20 years of global...

    Read more
  • Business
    14 October 2016

    Alvotech scores in Barcelona

    Over 40 managers from Alvotech and Alvogen attended CPhI last week for the fifth time. CPhI is the premiere event of the year in the pharma industry calendar and the...

    Read more
  • Business
    12 July 2016

    Generics Bulletin casts spotlight on Alvotech

    The latest issue of Generics bulletin, an international trade magazine, which covers news in the global generic medicines and biosimilars markets with subscribers in over 60 countries, features an in-depth...

    Read more
  • Business
    08 June 2016

    Alvotech opens state-of-the-art Biosimilar facility in Iceland

    Alvotech, today announces the opening of a new state-of-the-art facility, dedicated to the development and manufacturing of biosimilar monoclonal antibodies (“mAbs”). The opening of this industry leading biologics manufacturing plant...

    Read more
  • Business
    18 May 2016

    Acquisition of Baliopharm

    Alvotech today announced that it has closed on the acquisition of ​Baliopharm GmbH, a German biopharmaceutical development company, previously a subsidiary of Baliopharm AG. The acquisition provides Alvotech with complimentary...

    Read more
  • People
    04 February 2016

    Richard Davies new Chairman of the Board of Directors

    Alvotech is proud to announce Richard Davies as the Chairman of the Board of Directors. Richard has over 25 years of experience in the pharmaceutical and biotechnology industry. He is...

    Read more
  • Business
    17 September 2015

    Alvotech warming up for CPhI 2015 in Madrid

    This promises to be a busy and exciting fall for Alvotech. Once more it will be participating in the world’s largest pharmaceutical fair, CPhI, which this year is being hosted...

    Read more
  • People
    18 May 2015

    Alvotech recruits 40 professionals

    Alvotech has already recruited more than 40 new science professionals to its team, since it first broke ground in November 2013 with the building of a vast state-of-the-art development and...

    Read more
  • People
    24 March 2015

    Alvotech appoints Dr. Jennifer Hunt as VP of Operations

    Alvotech, a global biopharmaceutical company in the biosimilar monoclonal antibody market, announces that Dr. Jennifer Hunt has been appointed as Vice President of Operations. Dr. Jennifer Hunt will be responsible...

    Read more
  • People
    06 November 2014

    Alvotech opens 50 new positions

    Alvotech will be recruiting 50 new employees for its new state-of-the-art biomanufacturing facility in the science park of the University of Iceland in Reykjavik over the coming months. Some...

    Read more
  • Business
    16 October 2014

    Alvotech scores high at CPhI in Paris

    For the second year in a row, Alvogen stood out in the crowd at the annual CPhI event in October, which this year was hosted in Paris, France. CPhI is...

    Read more
  • Business
    25 May 2014

    Alvotech and Finesse collaborate

    Alvotech, a powerful new player in the field of biopharmaceuticals and Finesse Solutions, Inc. ("Finesse"), today announce that they have entered into a partnership that will provide Alvotech with world-class,...

    Read more
  • People
    12 March 2013

    Job openings at Alvotech

    Alvotech is a powerful new player in the field of biopharmaceuticals and is currently looking for team players. Would you like to become a part of the Alvotech team and...

    Read more
  • Business
    05 March 2013

    Alvotech invests $250 million in Biopharmaceuticals

    Alvotech, a powerful new player in the field of biopharmaceuticals, today announced plans to invest $250 million in the development and manufacturing of a portfolio of biosimilar monoclonal antibodies. -...

    Read more